VJHemOnc is committed to improving our service to you

BSH 2018 | Hodgkin lymphoma: difficulties faced in geriatrics

VJHemOnc is committed to improving our service to you

Wendy Osborne

At the British Society for Haematology (BSH) 2018 Annual Scientific Meeting, held in Liverpool, UK, Wendy Osborne, MBBS (Hons), MRCP, FRCPath, of Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, discusses the difficulties we face in treating Hodgkin Lymphoma (HL) within the geriatric population. In part, this is contributive to the heterogeneity of elderly patients with HL, making it difficult to ascertain a catch-all treatment decision. To resolve this, Dr Osborne suggests the utilization of geriatric assessment tools such as comorbidity scoring to resolve treatment decisions, including assessing how common treatments such as ABVD and bleomycin will affect an older population. Particularly, she notes the detrimental consequences peripheral neuropathy can have, which may not affect a younger cohort as extensively.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter